Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Goodenough AK et al. | Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis. | 2011 | Chem. Res. Toxicol. | pmid:21728364 |
Peters J et al. | Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals. | 2011 | Drug Metab. Dispos. | pmid:21690264 |
Diczfalusy U et al. | 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans. | 2011 | Br J Clin Pharmacol | pmid:21219398 |
Suzuki Y et al. | Significant increase in plasma 4β-hydroxycholesterol concentration in patients after kidney transplantation. | 2013 | J. Lipid Res. | pmid:23833241 |
Nury T et al. | Biological activities of the LXRα and β agonist, 4β-hydroxycholesterol, and of its isomer, 4α-hydroxycholesterol, on oligodendrocytes: effects on cell growth and viability, oxidative and inflammatory status. | 2013 | Biochimie | pmid:23220593 |
Björkhem-Bergman L et al. | Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study. | 2013 | Drug Metab. Dispos. | pmid:23386704 |
Shin KH et al. | Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance. | 2013 | Clin. Pharmacol. Ther. | pmid:23784264 |
van de Merbel NC and de Vries R | Aging of biological matrices and its effect on bioanalytical method performance. | 2013 | Bioanalysis | pmid:24066624 |
DeGorter MK et al. | Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care. | 2013 | Circ Cardiovasc Genet | pmid:23876492 |
Xu Y et al. | LC-ESI-MS/MS quantification of 4β-hydroxycholesterol and cholesterol in plasma samples of limited volume. | 2013 | J Pharm Biomed Anal | pmid:23948760 |